These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1667896)

  • 1. Experimental research about the influence of pentazocine and reserpine on morphine addiction.
    Stroescu V; Fulga IG; Turturoiu D; Toma A
    Rev Roum Physiol (1990); 1991; 28(1-2):3-11. PubMed ID: 1667896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat.
    Bhargava HN; Gulati A
    NIDA Res Monogr; 1990; 105():530-1. PubMed ID: 1652091
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
    Ignar DM; Kuhn CM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
    Tamdee D; Charuluxananan S; Punjasawadwong Y; Tawichasri C; Patumanond J; Sriprajittichai P
    Anesth Analg; 2009 Nov; 109(5):1606-11. PubMed ID: 19843798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
    Picker MJ; Craft RM; Negus SS; Powell KR; Mattox SR; Jones SR; Hargrove BK; Dykstra LA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):668-81. PubMed ID: 1331411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
    Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fear inhibitory properties of GABAA and μ opioid receptors of the dorsal periaqueductal grey in alcohol-withdrawn rats.
    Silva LBC; Nobre MJ
    Acta Neurobiol Exp (Wars); 2014; 74(1):54-66. PubMed ID: 24718044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interoceptive conditioning through repeated suppression of morphine-abstinence. I. Basis for conditioning: once-daily vs. continuous intravenous morphine infusion.
    Dougherty JA; Miller DB; Wikler A
    Pavlov J Biol Sci; 1979; 14(3):160-9. PubMed ID: 264013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
    Asensio VJ; Miralles A; García-Sevilla JA
    Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reserpine ulcers in morphine dependent and withdrawal rats.
    Lastowski Z; Siwiec V; Jedynak A
    Pol J Pharmacol Pharm; 1992; 44(1):41-9. PubMed ID: 1437851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of mu, delta and kappa receptors in morphine-induced tolerance in the guinea pig myenteric plexus.
    Leedham JA; Bennett LE; Taylor DA; Fleming WW
    J Pharmacol Exp Ther; 1991 Oct; 259(1):295-301. PubMed ID: 1656024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
    Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
    Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.